| Medical and Health Sciences | Lifetime | 802 | FR 16 | 99.96 |
| Medical and Health Sciences | 2021-2025 | 855 | FR 27 | 99.80 |
| Epidemiology | Lifetime | 158 | FR 8 | 99.80 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 126 | FR 2 | 99.59 |
| Critical Care and Intensive Care Medicine | Lifetime | 38 | FR 5 | 99.31 |
| Pulmonary and Respiratory Medicine | Lifetime | 614 | FR 32 | 99.11 |
| Clinical Neurology | Lifetime | 532 | FR 19 | 97.65 |
| Emergency Medicine | Lifetime | 877 | FR 20 | 89.20 |
| Epidemiology | 2021-2025 | 245 | FR 9 | 98.15 |
| Infectious Diseases | 2021-2025 | 158 | FR 4 | 97.36 |
| Clinical Neurology | 2021-2025 | 189 | FR 8 | 94.78 |
| Adrenal Hormones and Disorders | Lifetime | 3 | FR 1 | 99.84 |
| Sepsis Diagnosis and Treatment | Lifetime | 8 | FR 1 | 99.92 |
| Long-Term Effects of COVID-19 | Lifetime | 16 | FR 1 | 99.67 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 18 | FR 3 | 99.80 |
| COVID-19 Clinical Research Studies | Lifetime | 67 | FR 2 | 99.53 |
| Thermal Regulation in Medicine | Lifetime | 12 | FR 1 | 99.51 |
| Respiratory Support and Mechanisms | Lifetime | 108 | FR 8 | 99.60 |
| Electrolyte and hormonal disorders | Lifetime | 51 | FR 1 | 99.12 |
| Hormonal Regulation and Hypertension | Lifetime | 181 | FR 5 | 99.02 |
| Hemodynamic Monitoring and Therapy | Lifetime | 303 | FR 22 | 98.11 |
| Cardiac Arrest and Resuscitation | Lifetime | 680 | FR 35 | 98.26 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 917 | FR 32 | 97.24 |
| Clinical Reasoning and Diagnostic Skills | Lifetime | 200 | FR 1 | 96.28 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 307 | FR 8 | 96.15 |
| Pituitary Gland Disorders and Treatments | Lifetime | 744 | FR 45 | 96.52 |
| Renal function and acid-base balance | Lifetime | 385 | FR 11 | 96.21 |
| Myasthenia Gravis and Thymoma | Lifetime | 372 | FR 18 | 95.68 |
| Peripheral Neuropathies and Disorders | Lifetime | 468 | FR 28 | 96.43 |
| Nosocomial Infections in ICU | Lifetime | 496 | FR 62 | 95.55 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 454 | FR 9 | 95.40 |
| Inflammation biomarkers and pathways | Lifetime | 337 | FR 26 | 83.80 |
| Vagus Nerve Stimulation Research | Lifetime | 564 | FR 8 | 85.33 |
| Biomedical and Chemical Research | Lifetime | 570 | FR 15 | 81.16 |
| COVID-19 Clinical Research Studies | 2021-2025 | 87 | FR 3 | 99.46 |
| Long-Term Effects of COVID-19 | 2021-2025 | 74 | FR 2 | 98.95 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 29 | FR 3 | 99.38 |
| Adrenal Hormones and Disorders | 2021-2025 | 18 | FR 3 | 98.17 |
| Thermal Regulation in Medicine | 2021-2025 | 19 | FR 1 | 94.93 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 603 | FR 20 | 97.60 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 320 | FR 26 | 94.56 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 65 | FR 3 | 95.43 |
| Respiratory Support and Mechanisms | 2021-2025 | 587 | FR 59 | 93.96 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 738 | FR 45 | 83.24 |
| Complement system in diseases | 2021-2025 | 495 | FR 51 | 79.45 |
| Disaster Response and Management | 2021-2025 | 971 | FR 13 | 72.46 |
| Electrolyte and hormonal disorders | 2021-2025 | 742 | FR 20 | 64.32 |
| Vitamin C and Antioxidants Research | 2021-2025 | 969 | FR 11 | 51.69 |
